Nuvalent’s (NUVL) “Outperform” Rating Reaffirmed at Wedbush
Wedbush reiterated their outperform rating on shares of Nuvalent (NASDAQ:NUVL – Free Report) in a research report released on Tuesday morning,RTT News reports. Wedbush currently has a $115.00 price objective on the stock. A number of other equities research analysts have also issued reports on the company. Leerink Partners upped their price target on Nuvalent […]
Wedbush reiterated their outperform rating on shares of Nuvalent (NASDAQ:NUVL – Free Report) in a research report released on Tuesday morning,RTT News reports. Wedbush currently has a $115.00 price objective on the stock. A number of other equities research analysts have also issued reports on the company. Leerink Partners upped their price target on Nuvalent […]
